Healthcare & Life Sciences
Immunicom
United Statesimmunicom.com/
Immunicom is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Immunicom
Based in the United States, Immunicom is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Immunicom develops immunotherapies using its Immunopheresis® technology, a therapeutic device that filters blood outside the body to remove immune-blocking factors, aiming to treat cancer and other diseases by enhancing the immune response.
Explore Immunicom's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.